Correlation Between Oncternal Therapeutics and AnaptysBio

Can any of the company-specific risk be diversified away by investing in both Oncternal Therapeutics and AnaptysBio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oncternal Therapeutics and AnaptysBio into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Oncternal Therapeutics and AnaptysBio, you can compare the effects of market volatilities on Oncternal Therapeutics and AnaptysBio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oncternal Therapeutics with a short position of AnaptysBio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oncternal Therapeutics and AnaptysBio.

Diversification Opportunities for Oncternal Therapeutics and AnaptysBio

0.36

Correlation Coefficient

Oncternal Therapeutics  AnaptysBio

Weak diversification

The 3 months correlation between Oncternal and AnaptysBio is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Oncternal Therapeutics and AnaptysBio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AnaptysBio and Oncternal Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oncternal Therapeutics are associated (or correlated) with AnaptysBio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AnaptysBio has no effect on the direction of Oncternal Therapeutics i.e., Oncternal Therapeutics and AnaptysBio go up and down completely randomly.

Pair Corralation between Oncternal Therapeutics and AnaptysBio

Given the investment horizon of 90 days Oncternal Therapeutics is expected to generate 1.92 times more return on investment than AnaptysBio. However, Oncternal Therapeutics is 1.92 times more volatile than AnaptysBio. It trades about 0.13 of its potential returns per unit of risk. AnaptysBio is currently generating about -0.28 per unit of risk. If you would invest  105.00  in Oncternal Therapeutics on August 13, 2024 and sell it today you would earn a total of  22.00  from holding Oncternal Therapeutics or generate 20.95% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Oncternal Therapeutics  vs.  AnaptysBio

Oncternal Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Oncternal Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

AnaptysBio

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days AnaptysBio has generated negative risk-adjusted returns adding no value to investors with long positions. Despite inconsistent performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Oncternal Therapeutics and AnaptysBio

The main advantage of trading using opposite Oncternal Therapeutics and AnaptysBio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oncternal Therapeutics position performs unexpectedly, AnaptysBio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AnaptysBio will offset losses from the drop in AnaptysBio's long position.

The idea behind Oncternal Therapeutics and AnaptysBio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.